Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Development of clinical-stage anticancer drug stopped

April 4, 2002

Alizyme gets green light for phase Ib trial of ATL-104

April 3, 2002

Xcellerated T Cells evaluated in hormone-refractory prostate cancer

April 3, 2002

Pharmacokinetic and preliminary toxicological data presented for NSC-707545

April 3, 2002

17alpha-Methyltestosterone inhibits testosterone-induced breast cancer cell growth

April 3, 2002

Potential of hedgehog antagonists in the treatment of basal cell carcinoma

April 2, 2002

Suberanilohydroxamic acid decreases production of proinflammatory cytokines in vivo

April 2, 2002

Antiangiogenic pyridopyrimidinones in development at Pfizer

April 2, 2002

Pharmacia studies new kinase inhibitors and potential uses

April 2, 2002

Intrauterine growth restriction demonstrated for TNP-470 in later stages of pregnancy

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...